BESSEMER GROUP INC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q2 2022$93,000
-4.1%
1,5380.0%0.00%
Q1 2022$97,000
-17.1%
1,5380.0%0.00%
Q4 2021$117,000
-32.0%
1,5380.0%0.00%
Q3 2021$172,000
-30.9%
1,5380.0%0.00%
-100.0%
Q2 2021$249,000
+33.2%
1,5380.0%0.00%
Q1 2021$187,000
-20.4%
1,5380.0%0.00%
-100.0%
Q4 2020$235,000
+1707.7%
1,538
+754.4%
0.00%
Q2 2020$13,0001800.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$32,581,00055.55%
NEA Management Company, LLC 1,590,002$103,907,0005.19%
ARK Investment Management 8,237,122$538,296,0003.75%
Nikko Asset Management Americas, Inc. 4,262,736$277,078,0003.54%
CLOUGH CAPITAL PARTNERS L P 414,767$27,105,0002.89%
Integral Health Asset Management, LLC 220,000$14,377,0002.79%
PLUSTICK MANAGEMENT LLC 50,000$3,268,0002.48%
HC Advisors, LLC 53,944$3,525,0002.43%
Green Alpha Advisors, LLC 27,466$1,795,0001.52%
EFG Asset Management (North America) Corp. 84,356$5,516,0001.28%
View complete list of CRISPR THERAPEUTICS AG shareholders